Lucid Diagnostics (LUCD) Enterprise Value (2021 - 2025)
Lucid Diagnostics (LUCD) has disclosed Enterprise Value for 5 consecutive years, with -$47.3 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Enterprise Value fell 226.68% year-over-year to -$47.3 million, compared with a TTM value of -$47.3 million through Sep 2025, down 226.68%, and an annual FY2024 reading of -$22.4 million, down 18.32% over the prior year.
- Enterprise Value was -$47.3 million for Q3 2025 at Lucid Diagnostics, down from -$31.1 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$21336.0 in Q3 2021 and bottomed at -$53.7 million in Q4 2021.
- Average Enterprise Value over 5 years is -$25.9 million, with a median of -$24.9 million recorded in 2024.
- Peak annual rise in Enterprise Value hit 58.11% in 2022, while the deepest fall reached 126137.35% in 2022.
- Year by year, Enterprise Value stood at -$53.7 million in 2021, then skyrocketed by 58.11% to -$22.5 million in 2022, then increased by 15.92% to -$18.9 million in 2023, then decreased by 18.32% to -$22.4 million in 2024, then plummeted by 111.7% to -$47.3 million in 2025.
- Business Quant data shows Enterprise Value for LUCD at -$47.3 million in Q3 2025, -$31.1 million in Q2 2025, and -$25.2 million in Q1 2025.